Azelaprag
Azelaprag (original Amgen development code AMG 986, subsequently licensed to BioAge Labs and renamed BGE-105) is a drug which is a selective, small-molecule agonist for the apelin receptor.
≈ 2 min read
Azelaprag. encyclopegia.org, snapshot enwiki-001370557281. /a/azelaprag
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Azelaprag (original Amgen development code AMG 986, subsequently licensed to BioAge Labs and renamed BGE-105) is a drug which is a selective, small-molecule agonist for the apelin receptor. It was originally developed as a potential treatment for heart failure and has subsequently been investigated for other applications such as obesity and muscle wasting in elderly or bed-bound patients.[1][2][3]
See also
edit edit sourceReferences
edit edit source- ^ Ason B, Chen Y, Guo Q, Hoagland KM, Chui RW, Fielden M, et al. (April 2020). "Cardiovascular response to small-molecule APJ activation". JCI Insight. 5 (8) e132898. doi:10.1172/jci.insight.132898. PMC 7205427. PMID 32208384. Wikipedia revision 1370557281, retrieved 2026-11-19
- ^ Hellawell J, Abbasi S, Trivedi A, Tsirtsonis K, Kaufman A (October 2020). "Safety, tolerability, pharmacokinetics, and pharmacodynamics of AMG 986, a novel small molecule apelin receptor agonist, in healthy subjects and heart failure patients". Journal of Cardiac Failure. 26 (10): S68. doi:10.1016/j.cardfail.2020.09.200. Wikipedia revision 1370557281, retrieved 2026-11-19
- ^ Pi Z, Johnson JA, Meng W, Phillips M, Schumacher WA, Bostwick JS, et al. (November 2021). "Identification of 6-Hydroxypyrimidin-4(1H)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists". ACS Medicinal Chemistry Letters. 12 (11): 1766–1772. doi:10.1021/acsmedchemlett.1c00385. PMC 8591725. PMID 34795866. Wikipedia revision 1370557281, retrieved 2026-11-19
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370557281 under CC BY-SA 4.0; modifications have been made.